Biocartis NV
- Home
- Companies
- Biocartis NV
- Products
- Biocartis - Model ctKRAS - Fully ...
Biocartis -Â Model ctKRAS - Fully Automated Mutation Test Covers System
FromBiocartis NV
The fully automated Idylla ctKRAS Mutation Test is minimally invasive, fast and easy to perform and can be used as complement to tissue testing to determine the RAS mutation status at diagnosis. IdyllaTM ctKRAS covers 21 KRAS mutations in exons 2,3 and 4 and showed an high concordance to NGS of 96% using plasma samples from 198 mCRC patients enrolled in the prospective multicenter RASANC study.1
Most popular related searches
patient enrollment
oncology biomarker
oncology assay
biomarker test
biomarker testing
oncology
oncology testing
biomarker
Specimen requirements
One of the biggest challenges in oncology biomarker testing is the ability to obtain samples of sufficient size and quality. With the IdyllaTM system only a minimal amount of sample is needed
- 1 ml plasma collected in Streck tubes (process within 3 days)